<DOC>
	<DOCNO>NCT02882581</DOCNO>
	<brief_summary>The general purpose trial investigate whether metformin take breast tumor . Studies last year show effect metformin cell proliferation breast cancer . It though unclear whether effect tumor direct , indirect combination two . The investigator plan : - investigate metformin take breast cancer use novel 11C-metformin tracer positron emission tomography ( PET ) - investigate whether uptake correlated amount organic cation transporter ( OCT1-3 , MATE 1 &amp; 2 PMAT ) use quantitive polymerase chain reaction ( qPCR ) .</brief_summary>
	<brief_title>Metformin Breast Cancer , Visualized With Positron Emission Tomography</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>50 year C. mammae Tumor size : &gt; 10 mm diameter Unilateral cancer WHO performance status 01 Severe heart kidney failure Pregnant breast feeding If patient find eligible participation study p√• principal investigator</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Organic cation transporter</keyword>
	<keyword>Multidrug toxin extrusion</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>positron emission tomography</keyword>
</DOC>